Investing-News.Com
Information for Investors

COMPUGEN LTD, (CGEN) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

COMPUGEN LTD, (CGEN) Stock Research Free Stock Rating

 
Company Profile
 
Compugen, Ltd. develops platforms, discovery engines, and related technologies that enable the discovery and analysis of genes and gene-based products, as well as mRNAs and proteins. Its platforms comprise LEADS computational biology platform, which analyzes genomic and expressed sequence data to enable discovery of genes, mRNAs, and proteins; and discovery engines that enable its researchers to identify proteins and mRNAs with predetermined properties for therapeutic and diagnostic development. The company initiates the predictive modeling of alternative splicing, antisense, and the RNA editing that provides the basis for understandings of additional biological phenomena. Compugen has an early stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the company; and additional discoveries that are out-licensed for development. It also focuses on novel splice variants of known and validated therapeutic proteins, as well as novel diagnostic markers. These novel proteins constitute an intellectual property portfolio, which includes novel prostate specific antigens, a novel vascular endothelial growth factor, a splice variant of CD40, and other proteins. The company operates primarily in the United States, Israel, Europe, and the Far East. Compugen has a collaboration agreement with Ortho-Clinical Diagnostics, Inc. for the development and commercialization of immunoassay diagnostic markers. The company was established in 1993 and is headquartered in Tel Aviv, Israel.

COMPUGEN LTD Related

Compugen Compugen, a genomics-based drug and diagnostic discovery company, increases the ... Compugen Ltd. to Review Third Quarter 2008 Results on Thursday, November 13, ...
Compugen - IT Infrastructure and Lifecycle Solutions Compugen IT Asset Disposition Program Helps Customers Solve e-Waste Problems, ... Compugen, a leader in IT for Municipal Government, sponsors MISA BC (Municipal ...
CGEN: Summary for COMPUGEN LTD - Yahoo! Finance Get detailed information on COMPUGEN LTD (CGEN) including quote performance, ... Compugen Ltd. to Review Third Quarter 2008 Results on Thursday, November 13, ...
Sponsored Links:

Software Forces COMPUGEN LTD Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in COMPUGEN LTD buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on COMPUGEN LTD. This software is specially designed to give precision entry and exit points on COMPUGEN LTD, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When COMPUGEN LTD Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even COMPUGEN LTD, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: visteon corp connersville  the prudent speculator  stock market predictions 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Compugen Reports Third Quarter 2008 Financial Results (Business Wire)

Q3 2008 Compugen Earnings Release - Before Market Open (CCBN)

Compugen Chairman Presents Company Overview and Plans for 2009 at Rodman & Renshaw Healthcare Conference (Business Wire)

Compugen Appoints Martin Gerstel CEO Effective January 2009 (Business Wire)

Compugen Has No Intention of Issuing Equity at Current Market Value (Business Wire)

Compugen to Present at Rodman & Renshaw Healthcare Conference (Business Wire)

Compugen Ltd. to Review Third Quarter 2008 Results on Thursday, November 13, 2008 (Business Wire)

Compugen Announces New Discovery Platform to Identify Viral Peptides for Use as Human Anti Inflammatory Drugs (Business Wire)

Compugen Discovers Peptide Drug Candidate for Treatment of Solid Tumor Cancers and Announces Positive In Vivo Results (Business Wire)

Leviev Group, Evogene and Orfuel to Establish a Biodiesel Company in Namibia, Africa (Marketwire)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.